Item 6. Exhibits
4K characters. Original on sec.gov ·
Item 6. Exhibits
| (a) Exhibits | Description of Exhibits | Filed with this Form 10-Q | Incorporation by Reference | ||||||||||||||
| Form | Filing Date | Exhibit No. | |||||||||||||||
| 10.1* | Charles River Laboratories International, Inc. 2026 Long-term Incentive Plan | 8-K | May 11, 2026 | 10.1 | |||||||||||||
| 10.2* | Charles River Laboratories International, Inc. Form of Restricted Stock Unit granted under the 2026 Long-Term Incentive Plan - United States | X | |||||||||||||||
| 10.3* | Charles River Laboratories International, Inc. Form of Performance Share Unit granted under the 2026 Long-Term Incentive Plan - United States | X | |||||||||||||||
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer | X | |||||||||||||||
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer | X | |||||||||||||||
| 32.1+ | Certification of the Principal Executive Officer and the Principal Financial Officer required by Rule 13a-14(a) of 15d-14(a) of the Exchange Act | X | |||||||||||||||
| 101.INS | eXtensible Business Reporting Language (XBRL) Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | |||||||||||||||
| 101.SCH | XBRL Taxonomy Extension Schema Document | X | |||||||||||||||
| 101.CAL | XBRL Taxonomy Calculation Linkbase Document | X | |||||||||||||||
| 101.DEF | XBRL Taxonomy Definition Linkbase Document | X | |||||||||||||||
| 101.LAB | XBRL Taxonomy Label Linkbase Document | X | |||||||||||||||
| 101.PRE | XBRL Taxonomy Presentation Linkbase Document | X | |||||||||||||||
| * Management contract or compensatory plan, contract or arrangement | |||||||||||||||||
| + Furnished herein. |
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | |||||||||||
| August 5, 2026 | /s/ BIRGIT GIRSHICK | ||||||||||
| Birgit Girshick Chief Executive Officer | |||||||||||
| August 5, 2026 | /s/ GLENN COLEMAN | ||||||||||
| Glenn Coleman Corporate Executive Vice President and Chief Financial Officer |
Previous: Item 5. Other Information
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details